Lifestyle considerations in multiple myeloma - Takeaways - MDSpire

Lifestyle considerations in multiple myeloma

  • By

  • Yael N. Shapiro

  • Jeffrey M. Peppercorn

  • Andrew J. Yee

  • Andrew R. Branagan

  • Noopur S. Raje

  • Elizabeth K. O’ Donnell

  • October 26, 2021

  • 0 min

Share

  • 1

    Multiple myeloma (MM) is the second most common hematological malignancy in the U.S. and accounts for 1% of global cancer deaths.

  • 2

    New effective drugs have improved the five-year relative survival rate for MM patients to 55.6%, necessitating a focus on long-term quality of life.

  • 3

    MM patients experience a high symptom burden and low quality of life, highlighting the need for lifestyle interventions alongside pharmacological therapies.

  • 4

    Only 6.8% of MM patients meet physical activity guidelines during treatment, with significant barriers such as fatigue and lack of knowledge affecting participation.

  • 5

    41.1% of MM patients express willingness to join exercise programs, indicating a need for tailored interventions to improve physical activity in this population.

Original Source(s)

Lifestyle considerations in multiple myeloma

  • by Yael N. Shapiro, Jeffrey M. Peppercorn, Andrew J. Yee, Andrew R. Branagan, Noopur S. Raje, Elizabeth K. O’ Donnell

  • October 26, 2021

Related Content

Not all plasma cells are made equal: well-hidden layers of heterogeneity

Assessment of the Safety and Effectiveness of CD38-Targeted CAR-T Cell Therapy in Treating Multiple Myeloma: A Systematic Review and Meta-Analysis

Targeting CD38 Enzymatic Function in Antibody-Driven Immunotherapy for Multiple Myeloma: Insights from Basic Research